KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Buildings (2023 - 2025)

Edwards Lifesciences has reported Buildings over the past 3 years, most recently at $1.4 billion for Q4 2025.

  • Quarterly results put Buildings at $1.4 billion for Q4 2025, up 3.99% from a year ago — trailing twelve months through Dec 2025 was $1.4 billion (up 3.99% YoY), and the annual figure for FY2025 was $1.4 billion, up 3.99%.
  • Buildings for Q4 2025 was $1.4 billion at Edwards Lifesciences, up from $1.3 billion in the prior quarter.
  • Over the last five years, Buildings for EW hit a ceiling of $1.4 billion in Q4 2025 and a floor of $1.2 billion in Q4 2023.
  • Median Buildings over the past 3 years was $1.3 billion (2024), compared with a mean of $1.3 billion.
  • Biggest five-year swings in Buildings: grew 12.68% in 2024 and later increased 3.99% in 2025.
  • Edwards Lifesciences' Buildings stood at $1.2 billion in 2023, then rose by 12.68% to $1.3 billion in 2024, then grew by 3.99% to $1.4 billion in 2025.
  • The last three reported values for Buildings were $1.4 billion (Q4 2025), $1.3 billion (Q4 2024), and $1.2 billion (Q4 2023) per Business Quant data.